GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,643,000 | -17.6% | 13,266 | +10.7% | 0.00% | – |
| Q2 2016 | $5,635,000 | -87.9% | 11,989 | -62.2% | 0.00% | – |
| Q4 2015 | $46,666,000 | -17.2% | 31,746 | -11.0% | 0.00% | – |
| Q3 2015 | $56,346,000 | +146.4% | 35,662 | +165.1% | 0.00% | – |
| Q2 2015 | $22,872,000 | +504.8% | 13,454 | +394.5% | 0.00% | – |
| Q1 2015 | $3,782,000 | -97.9% | 2,721 | -96.9% | 0.00% | – |
| Q3 2014 | $179,302,000 | +9.0% | 87,041 | +61.9% | 0.00% | – |
| Q2 2014 | $164,540,000 | +20701.5% | 53,772 | +16547.7% | 0.00% | – |
| Q1 2014 | $791,000 | -88.9% | 323 | -77.5% | 0.00% | – |
| Q4 2013 | $7,113,000 | -82.3% | 1,434 | -91.9% | 0.00% | – |
| Q3 2013 | $40,258,000 | -47.6% | 17,657 | -49.0% | 0.00% | – |
| Q2 2013 | $76,843,000 | – | 34,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |